IL188021A0 - Non-steroidal progesterone receptor modulators - Google Patents

Non-steroidal progesterone receptor modulators

Info

Publication number
IL188021A0
IL188021A0 IL188021A IL18802107A IL188021A0 IL 188021 A0 IL188021 A0 IL 188021A0 IL 188021 A IL188021 A IL 188021A IL 18802107 A IL18802107 A IL 18802107A IL 188021 A0 IL188021 A0 IL 188021A0
Authority
IL
Israel
Prior art keywords
receptor modulators
progesterone receptor
steroidal progesterone
steroidal
modulators
Prior art date
Application number
IL188021A
Other languages
English (en)
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL188021A0 publication Critical patent/IL188021A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL188021A 2005-06-24 2007-12-10 Non-steroidal progesterone receptor modulators IL188021A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren
PCT/EP2006/006531 WO2006136461A2 (en) 2005-06-24 2006-06-22 Non-steroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
IL188021A0 true IL188021A0 (en) 2008-03-20

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188021A IL188021A0 (en) 2005-06-24 2007-12-10 Non-steroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1902049A2 (zh)
JP (1) JP2008543910A (zh)
KR (1) KR20080030622A (zh)
CN (1) CN101248066A (zh)
AR (1) AR054519A1 (zh)
AU (1) AU2006261048A1 (zh)
BR (1) BRPI0611903A2 (zh)
CA (1) CA2611897A1 (zh)
CR (1) CR9598A (zh)
DE (1) DE102005030292A1 (zh)
DO (1) DOP2006000148A (zh)
EA (1) EA200702524A1 (zh)
EC (1) ECSP078044A (zh)
GT (1) GT200600271A (zh)
IL (1) IL188021A0 (zh)
MX (1) MX2008000072A (zh)
NO (1) NO20080440L (zh)
PE (1) PE20070125A1 (zh)
TW (1) TW200740778A (zh)
UY (1) UY29624A1 (zh)
WO (1) WO2006136461A2 (zh)
ZA (1) ZA200800690B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2010002075A1 (en) * 2008-07-02 2010-01-07 Pharmacostech Co., Ltd. Methods for preparing amide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
JP2008529963A (ja) * 2003-07-01 2008-08-07 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 複素環式−置換されたペンタノール誘導体類、それらの生成方法及び抗炎症剤としてのそれらの使用

Also Published As

Publication number Publication date
ZA200800690B (en) 2009-09-30
DE102005030292A1 (de) 2007-01-11
TW200740778A (en) 2007-11-01
BRPI0611903A2 (pt) 2010-10-05
MX2008000072A (es) 2008-03-24
UY29624A1 (es) 2007-01-31
KR20080030622A (ko) 2008-04-04
CR9598A (es) 2008-04-09
GT200600271A (es) 2007-02-05
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
AU2006261048A1 (en) 2006-12-28
EA200702524A1 (ru) 2008-06-30
CA2611897A1 (en) 2006-12-28
CN101248066A (zh) 2008-08-20
ECSP078044A (es) 2008-01-23
DOP2006000148A (es) 2007-07-15
JP2008543910A (ja) 2008-12-04
PE20070125A1 (es) 2007-02-14
NO20080440L (no) 2008-03-25
EP1902049A2 (en) 2008-03-26
AR054519A1 (es) 2007-06-27

Similar Documents

Publication Publication Date Title
GB0400440D0 (en) Receptor modulators
ZA200704223B (en) Estrogen receptor modulators
IL182829A0 (en) Estrogen receptor modulators
EP2179061A4 (en) GREAT LIKE RECEPTOR MODULATORS
IL191766A0 (en) Gaba-b receptor modulators
GB0701992D0 (en) Grehlin Receptor Modulators
IL195997A0 (en) Catecholamine receptor modulation
IL191710A0 (en) Glucocorticoid receptor modulators as antiinflammatory agents
EP2139489A4 (en) Mineralocorticoid receptor modulators
IL188314A0 (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
DE602006005138D1 (de) Nichtsteroide glucocorticoid-rezeptormodulatoren
GB0622569D0 (en) Cannabinoid receptor modulators
ZA200800690B (en) Non-steroidal progesterone receptor modulators
EP2229167A4 (en) MINERALCORTICOIDREZEPTORMODULATOREN
EP1945213A4 (en) MODULATORS OF THE R3-PIPERIDINE-4-YL-INDOLE ORL-1 RECEPTOR
IL184532A0 (en) Novel adenosine a3 receptor modulators
ZA200806237B (en) Cannibinoid receptor modulators
DK2066677T3 (da) Pyridooxazepinprogesteronreceptormodulatorer
HK1096405A1 (en) Progesterone receptor modulators
ZA200801599B (en) Non-steroidal compounds useful as glucocorticoid receptor modulators
ZA200907546B (en) New progesterone receptor modulators
GB0516946D0 (en) Receptor
GB0625197D0 (en) Cannabinoid receptor modulators
GB0510253D0 (en) Receptor
GB0522394D0 (en) Receptor